盛志勇,李 毅

糖尿病创面的难愈性是全球糖尿病管理的重大挑战，其病理基础涉及神经病变、血管病变、炎症反应异常及氧化应激代谢紊乱的多因素协同作用。本文在发病机制、治疗进展层面进行总结分析，深化干细胞调控创面微环境的分子机制研究，并推动干细胞衍生物的临床转化，为糖尿病创面精准治疗提供理论依据与技术支撑。

糖尿病创面；干细胞治疗；研究机制

[1] DUNCAN B B,MAGLIANO D J,BOYKO E J.IDF diabetes atlas 11th edition 2025:global prevalence and projections for 2050[J]. Nephrology,dialysis,transplantation:official publication of the European Dialysis and Transplant Association-European Renal Association, 2025. [2] WANG N,JU S.[Research advances on the mechanism of refractory healing of diabetic foot ulcer][J].Zhonghua shao shang yu chuang mian xiu fu za zhi,2022,38(11):1085-9. [3] 12.Retinopathy,Neuropathy,and Foot Care:Standards of Care in Diabetes-2025[J].Diabetes care,2025,48(1 Suppl 1):S252-s65. [4] KOLLURU G K,BIR S C,KEVIL C G.Endothelial dysfunction and diabetes:effects on angiogenesis,vascular remodeling,and wound healing[J].International journal of vascular medicine,2012,2012:918267. [5] HOSSEINI A,ABDOLLAHI M.Diabetic neuropathy and oxidative stress:therapeutic perspectives[J].Oxidative medicine and cellular longevity,2013,2013:168039. [6] 何蕊,中华医学杂志刘J.糖尿病周围神经病变导致糖尿病足的机制[J].2016. [7] 糖尿病周围血管病变相关性糖尿病足中西医结合诊疗指南%J Chinese Journal of Clinical Healthcare[J].2025,28(2). [8] ISLAM K,ISLAM R,NGUYEN I,et al.Diabetes Mellitus and Associated Vascular Disease:Pathogenesis,Complications,and Evolving Treatments[J].Advances in Therapy,2025,42(6):2659-78. [9] KHAN A W,JANDELEIT-DAHM K A M.Atherosclerosis in diabetes mellitus:novel mechanisms and mechanism-based therapeutic approaches[J].Nature reviews Cardiology,2025,22(7):482-96. [10] ALAVI A,SIBBALD R G,MAYER D,et al.Diabetic foot ulcers:Part I.Pathophysiology and prevention[J].Journal of the American Academy of Dermatology,2014,70(1):1.e-.e18. [11] HE W F,YAN L F.[The regulatory role and related mechanisms of macrophages in wound healing][J].Zhonghua shao shang yu chuang mian xiu fu za zhi,2023,39(2):106-13. [12] KRZYSZCZYK P,SCHLOSS R,PALMER A,et al.The Role of Macrophages in Acute and Chronic Wound Healing and Interventions to Promote Pro-wound Healing Phenotypes[J].Frontiers in physiology,2018,9:419. [13] 中国糖尿病杂志朱J.糖尿病患者创面难愈机制及治疗研究进展[J].2016,(12):1135-9. [14] ROCHETTE L,ZELLER M,COTTIN Y,et al.Diabetes,oxidative stress and therapeutic strategies[J].Biochimica et Biophysica Acta(BBA)-General Subjects,2014,1840(9):2709-29. [15] YAMAGISHI S-I,MAEDA S,MATSUI T,et al.Role of advanced glycation end products(AGEs)and oxidative stress in vascular complications in diabetes[J].Biochimica et Biophysica Acta(BBA)-General Subjects,2012,1820(5):663-71. [16] 何萍,程涛,ISTIC郝J中年卷期-页.干细胞临床研究的现状及展望[J].2020. [17] 常琦圆,中国组织工程研究谭J.经血源性间充质干细胞生物学特性及在组织修复重建中的临床应用[J].2019,23(21):7. [18] 王珍.模拟创面微环境诱导的人脐带间充质干细胞外泌体对创面愈合的影响研究[D];遵义医科大学,2022. [19] ZHANG J M,AN J.Cytokines,inflammation,and pain[J].International anesthesiology clinics,2007,45(2):27-37. [20] TANG H,LUO H,ZHANG Z,et al.Mesenchymal Stem Cell-Derived Apoptotic Bodies:Biological Functions and Therapeutic Potential[J].2022,11(23):3879. [21] MIKŁOSZ A,CHABOWSKI A.Efficacy of adipose-derived mesenchymal stem cell therapy in the treatment of chronic micro-and macrovascular complications of diabetes[J].Diabetes,obesity&metabolism,2024,26(3):793-808. [22] 翟骁,王一然,朱明向,et al.间充质干细胞来源外泌体在氧化应激损伤中的研究进展[J].《第二军医大学学报》,39(7):716-21. [23] 赵智刚,赵智刚,邹萍,et al.骨髓间充质干细胞免疫学特征的研究进展[J].2009,(02):59-61. [24] 何萌陈,伍金林.间充质干细胞通过调控巨噬细胞极化实现免疫应答的研究现状[J][J].中华妇幼临床医学杂志,2019:15(5). [25] 李明1詹成2代曦煜1杨新宇冯.间充质干细胞临床应用的研究进展[J].复旦学报(医学版),2016,43(04):469. [26] KHAZAEI S,KESHAVARZ G,BOZORGI A,et al.Adipose tissue-derived stem cells:a comparative review on isolation,culture,and differentiation methods[J].Cell and Tissue Banking,2022,23(1):1-16. [27] IKEGAME Y,YAMASHITA K,HAYASHI S,et al.Comparison of mesenchymal stem cells from adipose tissue and bone marrow for ischemic stroke therapy[J].Cytotherapy,2011,13(6):675-85. [28] 章哲,刘明月,白朝.脐带间充质干细胞促进皮肤再生研究进展[J].中国麻风皮肤病杂志,2025,41(6):466-470.

点击下载PDF